Person: ÇELİKKALE, İLKE
9 results
Search Results
Now showing 1 - 9 of 9
Publication Bulky calcification on the left coronary cuspis causing to critical stenosis of LMCA ostium after a succesful TAVI procedure(2017-10-08T00:00:00Z) BAKSHALİYEV, NİJAD; NASİFOV, MAHARRAM; ENHOŞ, ASİM; ÖZDEN TOK, ÖZGE; KARAÇÖP, ERDEM; ULUGANYAN, MAHMUT; HUYUT, MUSTAFA AHMET; BACAKSIZ, AHMET; ÇELİKKALE, İLKE; AKDEMİR, BARIŞ; GÖKTEKİN, ÖMER; ENHOŞ, ASIM; KARAÇÖP, ERDEM; ULUGANYAN, MAHMUT; BACAKSIZ, AHMET; ÇELİKKALE, İLKEPublication -Mitral klip vakasında, transseptal ponksiyon sırasında aortik iyatrojenik perforasyonun, amplatzer ductal occluder ile başarılı kapatılması-(2019-04-28T00:00:00Z) ENHOŞ, ASİM; KAHRAMAN AY, NURAY; ULUGANYAN, MAHMUT; BAKSHALİYEV, NİJAD; YAMAÇ, AYLİN HATİCE; ÇELİKKALE, İLKE; İSMAİLOĞLU, ZİYA; BACAKSIZ, AHMET; ÖZDEMİR, RAMAZAN; ENHOŞ, ASIM; KAHRAMAN AY, NURAY; ULUGANYAN, MAHMUT; YAMAÇ, AYLİN HATİCE; ÇELİKKALE, İLKE; BACAKSIZ, AHMET; ÖZDEMİR, RAMAZANPublication Challenging case: Difficult crossing of severe aortic coarctation(2017-10-08T00:00:00Z) BAKSHALİYEV, NİJAD; NASİFOV, MAHARRAM; ÖZDEN TOK, ÖZGE; ENHOŞ, ASİM; KARAÇÖP, ERDEM; HUYUT, MUSTAFA AHMET; ÇELİKKALE, İLKE; AKDEMİR, BARIŞ; İSMAYILOĞLU, ZİYA; GÖKTEKİN, ÖMER; ENHOŞ, ASIM; KARAÇÖP, ERDEM; ÇELİKKALE, İLKEPublication Radiosefalik fistül darlığının endovasküler tedavisi(2017-09-24T00:00:00Z) ENHOŞ, ASİM; HUYUT, MUSTAFA AHMET; KARAÇÖP, ERDEM; BAKSHALİYEV, NİJAD; ÇELİKKALE, İLKE; ÖZDEMİR, RAMAZAN; ENHOŞ, ASIM; KARAÇÖP, ERDEM; ÇELİKKALE, İLKE; ÖZDEMİR, RAMAZANPublication MicroRNA 199a Is Downregulated in Patients After Coronary Artery Bypass Graft Surgery and Is Associated with Increased Levels of Sirtuin 1 (SIRT 1) Protein and Major Adverse Cardiovascular Events at 3-Year Follow-Up(2018-09-01T00:00:00Z) YAMAÇ, AYLİN HATİCE; Bakhshaliyev, Nijad; HUYUT, MUSTAFA AHMET; Yilmaz, Emre; ÇELİKKALE, İLKE; BACAKSIZ, AHMET; Demir, Yusuf; Demir, Ali Riza; Erturk, Mehmet; ÖZDEMİR, Ramazan; KILIÇ, ÜLKAN; YAMAÇ, AYLİN HATİCE; HUYUT, MUSTAFA AHMET; ÇELİKKALE, İLKE; BACAKSIZ, AHMET; BAKHSALIYEV, NIJAD; ÖZDEMİR, RAMAZANBackground: The cardioprotective protein SIRT1 is elevated in patients with coronary artery disease (CAD) to compensate for the disease-related adverse effects, but less is known about the prognostic role of SIRT 1 regulating microRNAs in patients after coronary artery bypass graft (CABG) surgery.Publication The prognostic value of fragmented QRS in patients undergoing transcatheter aortic valve implantation(2018-11-01) Ay, Nuray Kahraman; ENHOŞ, ASİM; AY, YASİN; Ozdemir, Razaman; NADİR, AYDIN; KARAÇÖP, ERDEM; ÇELİKKALE, İLKE; ULUGANYAN, MAHMUT; Goktekin, Omer; KAHRAMAN AY, NURAY; ENHOŞ, ASIM; AY, YASİN; BAKHSALIYEV, NIJAD; NADİR, AYDIN; KARAÇÖP, ERDEM; ÇELİKKALE, İLKE; ULUGANYAN, MAHMUT; ÖZDEMİR, RAMAZANBackground Although transcatheter aortic valve implantation (TAVI) can successfully correct aortic narrowing, pre-existing pathophysiological alterations in the left ventricle are still a concern in terms of long-term mortality. This study aimed to examine the predictive role of fQRS morphology on long-term prognosis in patients undergoing TAVI due to severe aortic stenosis. Methods A total of 117 patients undergoing TAVI due to severe aortic stenosis were included in this retrospective cohort study. Patients were assigned into two groups based on the presence (n = 36) or absence (n = 81) of fQRS. Predictors of long-term survival were estimated. Results In-hospital mortality was higher in fQRS group (5.5% vs. 1.2%, p = 0.0224). In the long-term, fQRS (OR: 3.06, 95% CI 1.29–7.27, p: 0.01), LVEF <50% (OR: 2.54, 95% CI 1.07–6.02, p: 0.03) and presence of atrial fibrillation (OR: 2.42, 95% CI 1.05–5.60, p: 0.03) emerged as significant independent predictors of short survival. Conclusion Presence of fQRS on ECG, an indirect indicator of myocardial fibrosis, seems to have the potential to be used as a prognostic marker after TAVI procedure. Large prospective studies are warranted.Publication KRANIAL SEPTIK EMBOLI İLE KOMPLIKE OLMUŞ BIKÜSPIT AORTIK KAPAK ENDOKARDITI: VAKA SUNUMU VE LITERATÜR DEĞERLENDIRMESI(2020-03-08T00:00:00Z) ÇELİKKALE, İLKE; BACAKSIZ, AHMET; İSMAYILOĞLU, ZİYA; BAKSHALİYEV, NİJAD; ENHOŞ, ASİM; KAHRAMAN AY, NURAY; KARAÇÖP, ERDEM; ÖZDEMİR, RAMAZAN; ÇELİKKALE, İLKE; BACAKSIZ, AHMET; ENHOŞ, ASIM; KAHRAMAN AY, NURAY; KARAÇÖP, ERDEM; ÖZDEMİR, RAMAZANPublication Transient complete atrioventricular block associated with ticagrelor therapy after acute coronary syndrome...(2017-10-08T00:00:00Z) ENHOŞ, ASIM; ÇELİKKALE, İLKE; HUYUT, MUSTAFA AHMET; karaçöp, erdem; bakshaliyev, nijad; ULUGANYAN, MAHMUT; YAMAÇ, AYLİN HATİCE; KAHRAMAN AY, NURAY; ismayiloğlu, ziya; ÖZDEMİR, RAMAZAN; ENHOŞ, ASIM; ÇELİKKALE, İLKE; ULUGANYAN, MAHMUT; YAMAÇ, AYLİN HATİCE; KAHRAMAN AY, NURAY; ÖZDEMİR, RAMAZANPublication Impact of atrial flow regulator (AFR) implantation on 12-month mortality in heart failure Insights from a single site in the PRELIEVE study(2021-08-01T00:00:00Z) BAKHSALIYEV, NIJAD; ÇELİKKALE, İLKE; ENHOŞ, Asim; KARAÇÖP, ERDEM; ULUGANYAN, Mahmut; ÖZDEMİR, Ramazan; BAKHSALIYEV, NIJAD; ÇELİKKALE, İLKE; ENHOŞ, ASIM; KARAÇÖP, ERDEM; ULUGANYAN, MAHMUT; ÖZDEMİR, RAMAZANBackground Implantation of the atrial flow regulator (AFR) to create an interatrial left-to-right shunt has been shown to be safe and feasible to reduce intracardiac filling pressures in patients with heart failure (HF). Objectives We aimed to assess the effect of AFR implantation on 12-month mortality and hospitalization rates in patients with reduced (HFrEF) or preserved HF (HFpEF). Methods One-year follow-up data from 34 subjects enrolled at a single PRELIEVE center were analyzed. The 12-month predicted mortality was calculated using the Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) risk score. Patients were divided into two groups, according to their history of hospitalizations for HF. Results Study data of 34 patients (HFrEF: 24 [70.6%]; HFpEF: 10 [29.4%]) were assessed. Median follow-up duration was 355 days. In total, 14 (41.2%) patients were hospitalized during the follow-up period and 6 (17.6%) of these patients were hospitalization for HF (HHF). A total of 24 hospitalizations occurred in this period and 8 (33%) hospitalizations were for HHF. The median baseline MAGGIC score was 23 and the median predicted mortality was 13.4/100 patient years. Observed mortality was 3.1/100 patient years. The observed survival (97%) was 10.3% (95% confidence interval 3.6-17.5%, p = 0.004) better than the predicted survival (86.6%). Conclusion Our results suggest that AFR implantation has favorable effects on mortality in patients with heart failure, regardless of ejection fraction. Furthermore, compared to baseline, left ventricular filling pressure (assessed by echocardiography) decreased significantly without right side volume overload at the 1-year follow-up.